Dr. Francesca Rosaria Bagnato, MD

Dr. Bagnato practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Bagnato's NPI, 1801189329, was assigned on May 17, 2011. Dr. Bagnato graduated from Sapienza University of Rome in 1996. Dr. Bagnato holds Tennessee license MD53414.

Dr. Bagnato's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Bagnato's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Bagnato is also affiliated with Marshall Medical Center South. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Bagnato to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bagnato practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bagnato's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Bagnato's licenses on file in 2 states: Tennessee and Kentucky.

Dmand AI lists lower back pain and multiple sclerosis among the conditions Dr. Bagnato treats.

CMS data shows 24 Medicare services from Dr. Bagnato across 1 procedure code in 2024, all of them office visits, for 20 Medicare patients. Medicare paid $2,253 for them. Every service was in an office.

CMS counts 20 Medicare patients who saw Dr. Bagnato in 2024. 75% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bagnato's median patient age at 54, with 56% women.

In 2024, Dr. Bagnato wrote 218 Medicare Part D claims for 24 patients. 77% of them were for generic drugs. CMS names the drug for 154 of them, across 9 drugs with 11 or more claims each, at $282,428 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

Dr. Bagnato accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bagnato as offering telehealth.

Dmand AI links 133 papers to Dr. Bagnato, published from 2003 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Brain. Dr. Bagnato has published most often in J Neuroimaging. Dr. Bagnato's most frequent co-authors are Fredric K. Cantor, MD, Joseph Alan Frank, MD and Colin McKnight, MD.

Dmand AI links Dr. Bagnato to 1 clinical trial. Conditions studied include Multiple Sclerosis and Demyelinating Autoimmune Diseases, CNS.

CMS Open Payments shows 93 general payments to Dr. Bagnato from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Sanofi and Genzyme US Companies paid the most, $116,755.

Dr. Bagnato graduated from Sapienza University of Rome in 1996.

Dr. Bagnato is in network with 15 carriers, including Aetna, Cigna and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.